Verona Pharma — Merger or Acquisition (September 2025)
17 slides from Verona Pharma's merger presentation, Sep 10, 2025
Slide 1: Verona Pharma Employee Town Hall with Merck
Verona Pharma Employee Town Hall with Merck Friday, September 5, 2025
Slide 2: Forward-looking statement of Merck & Co., Inc.
Forward-looking statement of Merck & Co., Inc. This presentation of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upo
Slide 3: Additional information and where to find it
Additional information and where to find it In connection with the proposed transaction between Verona Pharma and Merck, Verona Pharma will file with the Securities and Exchange Commission (“SEC”) a proxy statement on Schedule 14A. Additionally, Verona Pharma may file other relevant materials with t
Slide 4: Participants in the solicitation
Participants in the solicitation Verona Pharma, Merck and certain of their directors and executive officers may be deemed to be participants in the solicitation of proxies from the shareholders of Verona Pharma in connection with the proposed transaction. Information about Verona Pharma’s directors
Slide 5: Welcome
5 Welcome Susan Neunaber Executive Director, Business Development Merck Integration Office
Slide 6: Today's agenda
1 Today’s agenda 6 Welcome 2 Executive message 3 Our commitment to you 4 What to expect next
Slide 7: Executive message
7 Executive message Jeff Simmons Chief of Staff, Chairman of the Board & CEO
Slide 8: Our commitment to you
8 Our commitment to you Carl Segerstrom SVP, Human Health HR
Slide 9: Our opportunity to bring together two science-driven companies
This is our opportunity to bring together two science-driven companies, combining Verona’s strong early launch success with Merck’s large commercial footprint and strengthening Merck’s growing cardio-pulmonary portfolio. We are looking forward to working with you We need your partnership, experience
Slide 10: Our retention approach
*If an employee resigns or is terminated for Cause during the Retention Period, no Retention amount or Severance package will be paid. Retention Period Your retention agreement states the duration of your retention period post Close. Retention Bonus The value of your retention bonus and other terms
Slide 11: Verona's Change in Control Severance Plan
After completing the requested knowledge transfer and provided you are not terminated for “cause” as defined in the Verona Employee Change in Control Severance Plan, you will be eligible for a severance package. 11 Verona’s Change in Control Severance Plan *Outplacement through severance period or u
Slide 12: What you can expect after close
Integration is the date after the Close when you will transition onto Our Company payroll administration, benefits, and programs & policies. Integration Timing: April 1, 2026 Your current day-to-day work will generally not change; however, over time you will be asked to participate in certain activi
Slide 13: Next steps with HR
13 Review materials you’re received so far such as your retention agreement, email pertaining to Verona 401(k) and the Employee Resource Guide. Continue to leverage your Verona team for all HR related questions. We are partnering closely with them to get you the information you need Next steps with
Slide 14: Frequently asked questions
Frequently asked questions Let’s go through answers to common queries. 14
Slide 15: Frequently asked questions on retention agreements
For more information on these topics, review the Employee Resource Guide provided to you with your Retention Agreement. We will continue to update the Frequently Asked Questions guide as we receive additional questions. What happens if I do not sign my retention agreement? If you choose not to sign
Slide 16: What to expect next
16 What to expect next Susan Neunaber Executive Director, Business Development Merck Integration Office
Slide 17: Thank you!
Thank you!
Verona Pharma — Merger or Acquisition (September 2025) on 6ix